🎉【Gate Singapore Flagship Event · Square Fun Quiz Challenge Day 1】
#TOKEN2049# is just around the corner, and Gate is bringing the heat to Singapore!
Token of Love Music Festival, Gate x Oracle Red Bull Racing Reception, and the F1 Race Viewing are all set to roll out!
Join Square Fun Quiz Challenge now, test how much you know about the events and share $100 BTC in rewards!
To join: Comment your answers (format: 1B 2A 3B 4C)
🎁 Rewards: 3 lucky winners each day → $10 BTC each
👑 Bonus: Answer all questions correctly for 3 days → Extra $10 BTC for Super Quiz King!
📖 Day 1 · Quiz (Single Choic
The identification of the executive director of Linghang Medical Biotechnology is exposed: Two founders of Conflux hold concurrent positions.
According to Gate News bot, the latest public information shows that Long Fan and Wu Ming, the two founders of Conflux, also serve as executive directors of the Hong Kong-listed company Leading Pharmaceutical Biotechnology.
Navi Pharmaceutical Biotechnology currently has a total market value of approximately HKD 371 million (equivalent to USD 47.26 million). Meanwhile, the total market value of Conflux (CFX) token has reached USD 393 million, ranking 138th in the cryptocurrency market capitalization leaderboard.
Earlier reports indicated that Pioneer Pharma Biotechnology (00399) announced that the company will sign a memorandum of understanding with Northwestern Foundation (the seller) and Conflux on June 30, 2025, with the intention of acquiring all the shares of the target company. This potential acquisition aims to assist the company in entering the digital innovation field, which will not only diversify the group’s business but is also expected to bring new profit growth points for the group.